Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical : Third Quarter Results 2014

11/12/2014 | 01:58am EDT

Koblenz - November 12, 2014: CompuGroup Medical AG today presented the financial report for the third quarter of 2014. The company, one of the leading global providers of eHealth solutions, achieved revenue of EUR 125.8 million, compared to EUR 111.4 million in the third quarter 2013. This represents 13 percent year-on-year growth of which 6 percent is organic growth at constant exchange rates.

The pharmacy software business had a particularly strong quarter with 15 percent organic growth in the established German and Italian operations and a further 20 percent growth contribution from the new companies acquired in Italy.

The doctor and dental software business in Europe also continued its positive development with 7 percent year-on-year organic growth at constant exchange rates. In Germany, a significant part of the growth is related to the telematics infrastructure and Electronic Health Card (eGK) pilot project. After the first nine months, the project is on track to meet all its objectives within the specified two year timeframe. This means that the telematics infrastructure network will be ready by 2016 for a potential nation-wide connection of all clinics and hospitals in Germany.

For the business in the United States, the positive trend from the start of 2014 fell off slightly in the third quarter. In terms of sales and order bookings, the outcome in the third quarter 2014 was higher than the same period last year, but sequentially lower than in the second quarter this year.

Operating profit (EBITDA) amounted to EUR 23.2 million compared to EUR 25.3 million in the third quarter last year. According to budget, the operating margins in 2014 remain lower than the Group's inherent potential due to a range of special activities and projects during this year. Cash net income increased from EUR 12.4 million in the third quarter 2013 to EUR 18.0 million in 2014 and Earnings per share (EPS) grew from EUR 0.11 the previous year to EUR 0.21.

Frank Gotthardt, CEO and Chairman of the Board of CompuGroup Medical AG, stated: "Our business is growing the way it should. In terms of profitability, our third quarter results include restructuring costs and temporarily low margins related to our recent acquisitions and we are making solid progress. On the other hand these acquired companies in Italy and The Netherlands greatly improve our market position there. All in all, I am happy with the progress we are making and we are on the right track to build an even stronger CGM for the future."

CompuGroup Medical reaffirms the full year 2014 guidance presented in the 2013 Annual Report. Group revenue is expected to be in the range of EUR 518 million to EUR 528 million (increased by 8 million euro through acquisitions made in 2014) and operating income (EBITDA) is expected to be in the range of EUR 100 million to EUR 110 million.

Conference Call for Journalists, Investors and Analysts:
The management board of CompuGroup Medical AG will go through the Q2 results at a conference for analysts and investors today at 15:00 hours CET.

You can participate in this conference call by dialing one of the following phone numbers:
+49 (0) 69 2 10 86 97 03 (Germany)
+44 (0) 16 16 01 89 02 (UK)
+1 (0) 21 53 05 44 95 (USA)
Participant code: 18 56 12 70

A presentation will be made available for download on the CompuGroup Medical website at www.cgm.com . The presentation can also be viewed live at https://compugroupG3.webex.com/

About CompuGroup Medical AG
CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of approximately EUR 500 million, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of over 400,000 doctors, dentists, hospitals, pharmacies and networks as well as other service providers. With locations in 19 countries and customers in 43 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 4,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for media representatives:
CompuGroup Medical AG
Oliver Bruzek
Vice President of Politics and Corporate Communication
T +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100

Download list
  • Download [0.3 MB, PDF]
Back to overview
Contact

Please contact us if you have any questions or concerns.

More
Scroll to Top
Send to a friendPrint pageService Tools:</form>
Products & Services
  • Physicians
  • Dentists
  • Pharmacy
  • Hospital
  • Laboratory
  • Insurance Company
  • Industry
  • Patient
Our locations
  • CGM Worldwide
Press
  • Press Releases
  • Contact for Journalists
Career
  • Why CGM?
  • CGM as a Progressive Employer
  • Working at CGM
  • Job Offers
About Us
  • At a glance
  • Management Board
  • Business Areas
  • Medical Technology
  • Investor Relations
distributed by

ę Publicnow 2014
All news about COMPUGROUP MEDICAL SOCIETAS EUROPAEA
09/21COMPUGROUP MEDICAL SE & CO. KGAA : Preliminary announcement of the publication of quarterl..
EQ
09/20COMPUGROUP MEDICAL : Deutsche Bank remains its Buy rating
MD
09/16COMPUGROUP MEDICAL : Warburg Research revises his opinion and turns to Neutral
MD
09/15COMPUGROUP MEDICAL : Receives a Sell rating from Baader Bank
MD
09/15COMPUGROUP MEDICAL : Receives a Buy rating from Warburg Research
MD
09/15COMPUGROUP MEDICAL : Gets a Sell rating from Baader Bank
MD
09/14COMPUGROUP MEDICAL : Receives a Buy rating from Jefferies
MD
09/14COMPUGROUP MEDICAL : áMedicaláannounces medium-termátargets foráEBITDA-margináfor the firs..
PU
09/14COMPUGROUP MEDICAL : announces medium-term targets for EBITDA-margin for the first time an..
EQ
09/14PRESS RELEASE : CompuGroup Medical announces medium-term targets for EBITDA-margin for the..
DJ
More news
Analyst Recommendations on COMPUGROUP MEDICAL SOCIETAS EUROPAEA
More recommendations
Financials
Sales 2021 1 022 M 1 198 M 1 198 M
Net income 2021 81,8 M 95,9 M 95,9 M
Net Debt 2021 504 M 590 M 590 M
P/E ratio 2021 50,8x
Yield 2021 0,74%
Capitalization 4 076 M 4 777 M 4 777 M
EV / Sales 2021 4,48x
EV / Sales 2022 4,17x
Nbr of Employees 8 030
Free-Float 48,8%
Chart COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | COP | DE0005437305 | MarketScreener
Technical analysis trends COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 77,30 €
Average target price 84,30 €
Spread / Average Target 9,06%
EPS Revisions
Managers and Directors
Dirk W÷ssner Chairman-Management Board & CEO
Michael Rauch Chief Financial Officer
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Sven Thomas MŘller Vice Chairman & Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SOCIETAS EUROPAEA-1.65%4 777
ORACLE CORPORATION33.20%235 949
SAP SE13.11%164 679
INTUIT INC.45.95%151 402
SERVICENOW, INC.18.85%128 536
DOCUSIGN, INC.22.04%53 368